ResearcherChungbuk National UniversityNo recent work listed
Sangkyu Park
Matched on ORCID iD 0000-0002-2928-7266; OpenAlex author ID A5100676690. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2018: 1 paper · 2019: none · 2020: 1 paper
Papers 2
- Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells. Co-author DOI 10.3892/ol.2019.11134↗
- A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model. Co-author DOI 10.2147/ott.s186606↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hyung‐Joo Kwon · 2 shared papers, 2018–2020 · strength 0.24
- Paper Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cel… DOI 10.3892/ol.2019.11134↗
- Paper A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft… DOI 10.2147/ott.s186606↗
- Younghee Lee · 2 shared papers, 2018–2020 · strength 0.24
- Paper Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cel… DOI 10.3892/ol.2019.11134↗
- Paper A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft… DOI 10.2147/ott.s186606↗
- Guang Jer Wu · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.